Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Sales | 143,096 | 131,211 | 157,999 | 188,121 | 118,718 |
| Cost of Goods | 83,862 | 70,390 | 73,561 | 78,349 | 61,096 |
| Gross Profit | 59,234 | 60,821 | 84,438 | 109,772 | 57,622 |
| Operating Expenses | 66,944 | 60,063 | 59,498 | 56,185 | 49,487 |
| Operating Income | -6,848 | 1,148 | 25,501 | 53,936 | 8,231 |
| Interest Expense | 3,975 | 46 | 25 | -93 | 65 |
| Other Income | 118 | 548 | 378 | 396 | 464 |
| Pre-tax Income | -10,705 | 1,650 | 25,854 | 54,425 | 8,630 |
| Income Tax | -4,372 | 1,530 | 10,117 | 19,354 | 2,205 |
| Net Income Continuous | -6,333 | 120 | 15,737 | 35,071 | 6,425 |
| Net Income | $-6,333 | $120 | $15,737 | $35,071 | $6,425 |
| EPS Basic Total Ops | -0.09 | 0.00 | 0.23 | 0.52 | 0.09 |
| EPS Basic Continuous Ops | -0.09 | 0.00 | 0.23 | 0.52 | 0.09 |
| EPS Diluted Total Ops | -0.09 | 0.00 | 0.22 | 0.50 | 0.09 |
| EPS Diluted Continuous Ops | -0.09 | 0.00 | 0.22 | 0.50 | 0.09 |
| EBITDA(a) | $3,594 | $10,623 | $33,749 | $62,224 | $16,246 |